| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel And Secretary
1 company
Kasinger James R. is a General Counsel And Secretary at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $4.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 3,182 | $46.78 | $148,853.96 | -3.3% | - | - | |
| Mar 16, 2026 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 3,450 | $48.26 | $166,497.00 | -3.6% | - | - | |
| Mar 11, 2026 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 2,800 | $52.80 | $147,840.00 | -3.1% | - | - | |
| Oct 14, 2025 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 1,076 | $66.60 | $71,661.60 | -1.3% | -20.3% | - | |
| Mar 21, 2025 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 3,185 | $41.23 | $131,317.55 | -3.8% | +7.4% | +12.2% | |
| Mar 12, 2025 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 3,966 | $42.67 | $169,242.12 | -2.5% | -1.3% | +12.4% | |
| Feb 19, 2025 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 11,542 | $53.67 | $619,492.35 | -7.2% | -26.0% | +3.1% | |
| Oct 14, 2024 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 1,089 | $46.28 | $50,398.92 | -1.7% | -18.8% | +45.1% | |
| Mar 12, 2024 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 3,947 | $77.15 | $304,514.50 | -3.2% | -20.3% | -42.2% | |
| Feb 20, 2024 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 1,913 | $79.67 | $152,408.71 | -3.2% | -29.5% | -32.7% |